Samdeep Mouli, MD
Vascular & Interventional Radiology · Nashville, TNNPI 1932375565
Payments from drug & device makers
Across 379 payments — averaging $7777.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2.4M
- Siemens Medical Solutions USA, Inc.$344K
- Guerbet LLC$175K
- Terumo Medical Corporation$30K
- Argon Medical Devices, Inc.$819
- Biocompatibles, Inc.$564
- plus $878 from 9 others
What the payments were for
- Consulting fees$142,64166%
- Speaking & faculty fees$44,55020%
- Travel & lodging$19,5199%
- Food & beverage$10,6215%
- Entertainment$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 278 | $2,395,829 |
| Siemens Medical Solutions USA, Inc. | 55 | $344,104 |
| Guerbet LLC | 6 | $175,210 |
| Terumo Medical Corporation | 24 | $30,276 |
| Argon Medical Devices, Inc. | 2 | $819 |
| Biocompatibles, Inc. | 1 | $564 |
| Cook Medical LLC | 2 | $264 |
| Bard Peripheral Vascular, Inc. | 2 | $193 |
| Balt USA, LLC | 1 | $138 |
| BTG International Canada Inc. | 1 | $127 |
| Medtronic | 2 | $61 |
| Penumbra, Inc. | 2 | $38 |
| Varian Medical Systems, Inc. | 1 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $20 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLINICAL TRIAL PRODUCT$33,776
- Navicross$20,784
- GlideWire$19,184
- GENERAL - THERAPIES$17,903
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$17,558
- Artis Q ceiling$9,489
- GENERAL PAIN MANAGEMENT$9,250
- GENERAL VASCULAR INTERVENTION$8,636
- GLIDESHEATH SLENDER$8,500
- GENERAL - IO ABLATION$6,375
- HydroPearl$5,600
- Optitorque$4,550
- Heartrail$4,550
- TheraSphere Y90 Glass Microspheres 10 GBq$4,474
- Artis Q floor$4,312
- OBSIDIO$2,981
- GENERAL EMBOLICS$2,800
- TRUSELECT$2,450
- EMBOLD Fibered$1,750
- THERASPHERE$1,513
How this compares
$2,947,681 in reported general payments places this provider in the 95th percentile of 76 vascular & interventional radiology providers in Tennessee.
See all vascular & interventional radiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 44 | $229 |
| Ciprofloxacin Hcl | 33 | $168 |
| Tamsulosin Hcl | 18 | $167 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Nashville
- Reed OmaryNashville$66K
- David ZielskeNashville$46K
- Nicholas VoutsinasNashville$39K
- Ryan MullerNashville$5K
- Andrew MarsalaNashville$3K
- Filip BanovacNashville$3K
- Ava StarNashville$2K
- William BarretNashville$2K
- Michelle LuschenNashville$2K
- Raj BantNashville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.